Type 2 diabetes trials recruiting in Texas

All Type 2 diabetes trials nationally

Cities in Texas

Recruiting trials in Texas

• A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
  NCT07351045 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Bellaire, Brownsville, Corpus Christi, Dallas
• A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
  NCT07351058 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Brownsville, Dallas, Edinburg, Houston
• A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
  NCT07667803 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas, Houston, Humble, Irving
• A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
  NCT07662044 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Fort Worth, Irving
• A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
  NCT07662135 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: San Antonio
• A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
  NCT07664553 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston, Round Rock, San Antonio
• A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
  NCT07662109 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas, McKinney, Paris, San Antonio
• A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
  NCT06112418 · Phase: Not applicable (e.g. observational or device study) · Ages: 55 Years and older · Sex: All (male and female) · Texas: Abilene, Beaumont, Greenville, Houston
• A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
  NCT07061574 · Phase: Phase 1, Phase 2 · Ages: 9 Years to 20 Years · Sex: All (male and female) · Texas: Houston
• A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
  NCT06717698 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Texas: El Paso, San Antonio
• A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
  NCT07415954 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Dallas, Houston, Shavano Park
• A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
  NCT07668388 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Austin, Houston, Lampasas, San Antonio
• A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
  NCT07564414 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Amarillo, Austin, Dallas, Euless
• A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
  NCT07282613 · Phase: Phase 3 · Ages: 10 Years to 18 Years · Sex: All (male and female) · Texas: Houston, Shavano Park
• A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
  NCT04786262 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: Dallas
• A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
  NCT07654374 · Phase: Phase 3 · Ages: 18 Years to 79 Years · Sex: All (male and female) · Texas: Austin, Farmers Branch, Houston, San Antonio
• A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
  NCT07340320 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Dallas, Mesquite, San Antonio, Stephenville
• A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
  NCT06739122 · Phase: Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · Texas: Dallas, Houston
• A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
  NCT07282600 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin, Corpus Christi, Dallas, Fort Worth
• A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
  NCT07321886 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Bellaire, Dallas, San Antonio
• A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
  NCT07392190 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas, Houston, Kingwood, Mission
• A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
  NCT06897475 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Houston, Mesquite, Round Rock, Shavano Park
• A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
  NCT07215559 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Dallas, Houston, Richmond, Shavano Park
• A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
  NCT07743450 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin, Brownsville, DeSoto, Frisco
• A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
  NCT07776509 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston
• A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
  NCT07784725 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston, San Antonio, Sugar Land, Waco
• A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
  NCT07219602 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston, San Antonio
• A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
  NCT07662213 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas, Houston, Katy, San Antonio
• A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
  NCT07024823 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: San Antonio
• A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
  NCT07589608 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Austin, Dallas, Houston, San Antonio
• A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
  NCT07595549 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston, San Antonio
• A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
  NCT07754461 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin, Brownsville, Conroe, Dallas
• ACT Intervention for Type 2 Diabetes Management for Rural and Underserved Community
  NCT06028503 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Conroe
• AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
  NCT07533175 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas, Houston
• AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
  NCT07797335 · Phase: Phase 3 · Ages: 45 Years and older · Sex: All (male and female) · Texas: Amarillo, Austin, Conroe, Corpus Christi
• Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes
  NCT06108076 · Phase: Early Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Texas: San Antonio
• Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents
  NCT06943001 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years to 16 Years · Sex: All (male and female) · Texas: Houston
• Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions
  NCT05168605 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 60 Years · Sex: All (male and female) · Texas: Dallas
• Balance Control and Recovery in Diabetes Peripheral Neuropathy
  NCT06544876 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 99 Years · Sex: All (male and female) · Texas: Austin
• Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems
  NCT06959277 · Phase: Not applicable (e.g. observational or device study) · Ages: 55 Years and older · Sex: All (male and female) · Texas: Galveston
• CGM for Management of Type 2 Diabetes in Pregnancy
  NCT06628453 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 50 Years · Sex: Female · Texas: Houston
• Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
  NCT05142189 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston
• Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes
  NCT06246799 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: San Antonio
• DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
  NCT06525259 · Phase: Not specified · Ages: 8 Years to 15 Years · Sex: All (male and female) · Texas: Houston
• Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis
  NCT05950282 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston
• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
  NCT07064473 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin, Brownsville, Dallas, El Paso
• Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
  NCT07579702 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years to 75 Years · Sex: All (male and female) · Texas: Houston
• Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.
  NCT06810726 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Texas: Corpus Christi
• Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
  NCT07521475 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Austin, McKinney, San Antonio
• Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
  NCT07684144 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Texas: Austin, Bellaire, Corpus Christi, Denison
• Feasibility and Adherence to a Technology-assisted Home-based Strength Training Program in Adults With Type 2 Diabetes Mellitus and Mild Cognitive Impairment
  NCT07416799 · Phase: Not applicable (e.g. observational or device study) · Ages: 55 Years to 80 Years · Sex: All (male and female) · Texas: Galveston
• GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
  NCT07228117 · Phase: Not applicable (e.g. observational or device study) · Ages: 7 Years to 85 Years · Sex: All (male and female) · Texas: Austin, Denton, McKinney
• Gastroparesis Registry 4
  NCT05846802 · Phase: Not specified · Ages: 18 Years to 85 Years · Sex: All (male and female) · Texas: El Paso
• Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes
  NCT06706284 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Texas: San Antonio
• HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
  NCT07546929 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas, Irving, Lewisville, McKinney
• Heat and Exercise in Aging as Therapy (HEAT)
  NCT06580964 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years and older · Sex: All (male and female) · Texas: Lubbock
• Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
  NCT06906640 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston, Temple
• Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
  NCT06906627 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Temple
• KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
  NCT06451757 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston
• Lean Beef as Part of a Healthy Meal Plan in Adolescents With Polycystic Ovary Syndrome (PCOS)/Polyendocrine Metabolic Ovarian Syndrome (PMOS)
  NCT07780188 · Phase: Not applicable (e.g. observational or device study) · Ages: 11 Years to 17 Years · Sex: Female · Texas: College Station
• NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
  NCT06593327 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female) · Texas: Dallas
• PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents
  NCT06959901 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Years to 18 Years · Sex: All (male and female) · Texas: Houston
• PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
  NCT05390892 · Phase: Phase 4 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Texas: Katy, McKinney
• Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
  NCT07502508 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Texas: Austin, Dallas, Houston, Lewisville
• Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets
  NCT07502495 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Austin, Dallas, Houston, Lewisville
• Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants
  NCT05838287 · Phase: Phase 4 · Ages: 30 Years to 70 Years · Sex: All (male and female) · Texas: San Antonio
• Polypill for Prevention of Cardiomyopathy
  NCT06143566 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 100 Years · Sex: All (male and female) · Texas: Dallas
• Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
  NCT02969798 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: San Antonio
• Quantifying Hepatic Mitochondrial Fluxes in Humans
  NCT05305287 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Texas: San Antonio
• RESET System Pivotal Trial (Rev F)
  NCT04101669 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 65 Years · Sex: All (male and female) · Texas: Houston
• ROME GS System Study
  NCT07518004 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: San Antonio
• Registry for Stage 2 Type 1 Diabetes
  NCT06481904 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Texas: Austin, Dallas, Fort Worth, Houston
• SALUD-M: Acceptance Based Coping Skills for Hispanic/Latinx Military Patients With Type 2 Diabetes
  NCT07674628 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · Texas: San Antonio
• SGLT2i, Hepatic Glucose Production, and SNS
  NCT07053293 · Phase: Early Phase 1 · Ages: 30 Years to 75 Years · Sex: All (male and female) · Texas: San Antonio
• SGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia
  NCT07053306 · Phase: Phase 1 · Ages: 30 Years to 75 Years · Sex: All (male and female) · Texas: San Antonio
• SGLT2i, Pioglitazone, and Ketone Production in T2D
  NCT07053319 · Phase: Phase 1 · Ages: 30 Years to 75 Years · Sex: All (male and female) · Texas: San Antonio
• SGLTi, Hepatic Glucose Production and Ketogenesis
  NCT05960656 · Phase: Phase 1 · Ages: 30 Years to 75 Years · Sex: All (male and female) · Texas: San Antonio
• Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
  NCT07599982 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · Texas: Austin
• Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
  NCT05267626 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin, Houston, San Antonio
• Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)
  NCT06562907 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Texas: San Antonio
• Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
  NCT07271186 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Texas: Arlington, Dallas, DeSoto, El Paso
• Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
  NCT07296484 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin, Dallas, Houston, Lampasas
• Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes
  NCT06593314 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female) · Texas: Dallas